Skip to main content
SpringerLink
Log in

Retinoblastoma

  • Chapter
  • First Online:
Ocular Oncology

Part of the book series: Retina Atlas ((RA))

Abstract

Retinoblastoma is the most common intraocular cancer of childhood (Shields and Shields 2015; JA and CL 1992; Kivela 2009; Ramasubramanian and Shields 2012a). This malignancy represents approximately 4% of all pediatric malignancies and carries a fairly high survival rate in developed nations. There has been a tremendous progress in retinoblastoma management over the past 20 years in the United States of America (USA) and abroad.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol. 1979;87:624–7.

    Article  CAS  Google Scholar 

  • Abramson DH, Frank CM, Susman M, et al. Presenting signs of retinoblastoma. J Pediatr. 1998;132:505–8.

    Article  CAS  Google Scholar 

  • Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108:1868–76.

    Article  CAS  Google Scholar 

  • Abramson DH, Shields CL, Munier FL, et al. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 2015;133:1341–7.

    Article  Google Scholar 

  • Ali AA, Elsheikh SM, Elhaj A, et al. Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single institution experience. Ophthalmic Genet. 2011;32:122–5.

    Article  Google Scholar 

  • Bader JL, Miller RW, Meadows AT, et al. Trilateral retinoblastoma. Lancet. 1980;2:582–3.

    Article  CAS  Google Scholar 

  • Boubacar T, Fatou S, Fousseyni T, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol. 2010;94:467–9.

    Article  Google Scholar 

  • Cao C, Markovitz M, Ferenczy S, et al. Hand-held spectral-domain optical coherence tomography of small macular retinoblastoma in infants before and after chemotherapy. J Pediatr Ophthalmol Strabismus. 2014;51:230–4.

    Article  Google Scholar 

  • Epstein JA, Shields CL, Shields JA. Trends in the management of retinoblastoma: evaluation of 1,196 consecutive eyes during 1974 to 2001. J Pediatr Ophthalmol Strabismus. 2003;40:196–203.

    Article  Google Scholar 

  • Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923–31.

    Article  Google Scholar 

  • Kaliki S, Shields CL, Shah SU, et al. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011;129:1422–7.

    Article  CAS  Google Scholar 

  • Kaliki S, Shields CL, Rojanaporn D, et al. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Ophthalmology. 2013;120:997–1003.

    Article  Google Scholar 

  • Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999;17:1829–37.

    Article  CAS  Google Scholar 

  • Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.

    Article  Google Scholar 

  • Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41–53.

    Article  CAS  Google Scholar 

  • Park K, Sioufi K, Shields CL. Clinically invisible retinoblastoma recurrence in an infant. Retin Cases Brief Rep. 2017. https://doi.org/10.1097/icb.0000000000000555.

    Article  Google Scholar 

  • Ramasubramanian A, Shields CL. Epidemiology and magnitude of the problem. Epidemiology and magnitude of the problem. Retinoblastoma. New Delhi, India: Jaypee Brothers Medical Publishers; 2012a.

    Google Scholar 

  • Ramasubramanian A, Shields CL. Staging and treatment strategies. In: Epidemiology and magnitude of the problem. Retinoblastoma. New Delhi, India: Jaypee Brothers Medical Publishers; 2012b.

    Google Scholar 

  • Saktanasate J, Vongkulsiri S, Khoo CT. Invisible retinoblastoma. JAMA Ophthalmol. 2015;133(7):e151123. https://doi.org/10.1001/jamaophthalmol.2015.1123.

    Article  PubMed  Google Scholar 

  • Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228–34.

    Article  Google Scholar 

  • Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21:203–12.

    Article  Google Scholar 

  • Shields JA, Shields CL. Intraocular tumors: an atlas and textbook. 3rd ed. Philadelphia: Wolters Kluwer; 2015.

    Google Scholar 

  • Shields CL, Shields JA, Baez KA, et al. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77:544–8.

    Article  CAS  Google Scholar 

  • Shields CL, Shields JA, Baez K, et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73:692–8.

    Article  CAS  Google Scholar 

  • Shields CL, Meadows AT, Shields JA, et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269–72.

    Article  CAS  Google Scholar 

  • Shields CL, Mashayekhi A, Demirci H, et al. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122(5):729–35. https://doi.org/10.1001/archopht.122.5.729.

    Article  PubMed  Google Scholar 

  • Shields CL, Ghassemi F, Tuncer S, et al. Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes. Ophthalmology. 2008;115:2253–8.

    Article  Google Scholar 

  • Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013a;27:253–64.

    Article  CAS  Google Scholar 

  • Shields CL, Schoenberg E, Kocher K, et al. Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology. 2013b;120:311–6.

    Article  Google Scholar 

  • Shields CL, Lally SE, Leahey AM, et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol. 2014;25:374–85.

    Article  Google Scholar 

  • Shields JA, Shields CL. A text and Atlas Philadelphia. In: In intraocular tumors. Philadelphia: Wolters Kluwer; 1992.

    Google Scholar 

  • Stathopoulos C, Say EAT, Shields CL. Intra-arterial and intravitreal chemotherapy for retinoblastoma. Curr Ophthalmol Rep. 2017;5:73–84.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wills Eye Hospital, Philadelphia, PA, USA

    Carol L. Shields & Sara E. Lally

  2. Department of Ophthalmology, Thomas Jefferson University, Philadelphia, PA, USA

    Carol L. Shields & Sara E. Lally

Authors
  1. Carol L. Shields
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara E. Lally
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol L. Shields .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    Duangnate Rojanaporn

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shields, C.L., Lally, S.E. (2019). Retinoblastoma. In: Rojanaporn, D. (eds) Ocular Oncology. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-2336-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2336-2_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2335-5

  • Online ISBN: 978-981-13-2336-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation